Chromium Picolinate for the Treatment of Metabolic Syndrome

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

December 31, 2005

Conditions

Metabolic Syndrome XPrediabetic StateInsulin ResistanceObesityMetabolic Diseases

Interventions

DRUG

Chromium picolinate

Trial Locations (1)

University of Pennsylvania, Philadelphia

All Listed Sponsors

lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00128154 - Chromium Picolinate for the Treatment of Metabolic Syndrome | Biotech Hunter | Biotech Hunter